US IPO Pipeline SEC S-1 Filings — September 14, 2026

14-09-2026

MiniMed Group, Inc. filed an S-4 registration statement in connection with its spin-off from Medtronic plc, which was completed on March 9, 2026. The filing provides comprehensive audited financial statements for fiscal years ended April 24, 2026, April 25, 2025, and April 26, 2024. Revenue grew 11.5% YoY to $3,089M in FY2026, driven by strong performance in Pumps (+12.7%) and Consumables (+13.0%), but Continuous Glucose Monitoring (CGM) systems revenue declined 2.1% YoY to $41.9M. Net income increased 14.5% to $349M, while operating income rose 13.0% to $477M.

• · The spin-off from Medtronic was completed on March 9, 2026, with MiniMed becoming an independent publicly traded company.
• · An IPO of common stock occurred on March 9, 2026, with proceeds used to fund the separation.
• · A $1.5B revolving credit facility was entered into on January 15, 2026.
• · A $50M charge was recorded in FY2026 for termination of a third-party manufacturing agreement.
• · The company is involved in a Diabetes Pump Retainer Ring Litigation, with lawsuits filed in California, Washington, and New York on April 1, 2026, and a subsequent event on June 17, 2026.
• · An international arbitration with EOFlow Co., Ltd. was initiated in June 2024.
• · Related-party transactions with Medtronic include allocated expenses, transition services, and amounts due to/from parent company.
• · U.S. revenue was $2,200M (71.2% of total) in FY2026, while non-U.S. revenue was $889M (28.8%).
• · Research and development expenses were $350M in FY2026, compared to $320M in FY2025 (9.4% increase).
• · Selling, general and administrative expenses were $1,200M in FY2026, compared to $1,080M in FY2025 (11.1% increase).

14-09-2026

Syra Health Corp (SYRA) filed an S-1 registration statement with the SEC on September 14, 2026, for a proposed initial public offering. The filing covers financial data for the six months ended June 30, 2026, and fiscal years 2024 and 2025, including segment performance for Healthcare Workforce and Population Health. The company has a history of losses, with accumulated retained earnings deficit, and relies on related-party transactions, including an office lease and IT services from RadCube LLC.

• · The filing includes financial data for the six months ended June 30, 2026, and fiscal years 2024 and 2025.
• · The company has segments: Healthcare Workforce and Population Health.
• · Related-party transactions include an office lease and IT services from RadCube LLC.
• · The company has a retained earnings deficit as of June 30, 2026.
• · The filing references an insurance policy financing arrangement dated April 2026.
• · Stock option and restricted stock awards were granted in December 2025.

14-09-2026

MFB Bancorp, Inc. filed an S-1 registration statement with the SEC on September 14, 2026, for an initial public offering of up to 1,190,250 shares of common stock at $10.00 per share, in connection with the conversion of Mutual Federal Bancorp, MHC from a mutual holding company to a fully public stock holding company. The offering is on a best-efforts basis with a minimum of 765,000 shares required to complete, and the company expects to issue up to 325,610 additional shares in exchange for existing public shares. As of June 30, 2026, Mutual Federal Bancorp had total assets of $96.6 million, deposits of $61.9 million, and stockholders' equity of $16.3 million, with 77.4% of shares held by Mutual Federal, MHC and 22.6% held by the public.

• · The offering price is $10.00 per share.
• · Minimum purchase order is 25 shares; maximum purchase is 25,000 shares ($250,000) per individual, or 30,000 shares ($300,000) per person/entity with associates.
• · Funds held in a segregated account at Mutual Federal Bank earn interest at 0.25% per annum until completion or termination.
• · The subscription offering expires at 5:00 p.m. Central Time on a date to be determined in 2026, with possible extensions up to 90 days each, subject to Federal Reserve approval.
• · Performance Trust Capital Partners, LLC is acting as marketing agent on a best-efforts basis and is not required to purchase any shares.
• · The company is an emerging growth company and a smaller reporting company.
• · The common stock is not insured by the FDIC or any other government agency.

14-09-2026

Air Lease Corporation (AL) filed an S-4 registration statement on September 14, 2026, in connection with an exchange offer to register up to $4.0 billion aggregate principal amount of exchange notes (2028, 2029, 2031, and 2036 series). The exchange offer is being made to satisfy registration rights obligations following the company's merger on April 8, 2026, which resulted in the company becoming an indirect subsidiary of Sumisho Air Lease Corporation Designated Activity Company, jointly owned by Sumitomo Corporation, SMBC Aviation Capital, Apollo, and Brookfield. The filing incorporates by reference the company's 2025 10-K, Q1 10-Q, and Q2 10-Q, and includes extensive risk factors related to the company's significant indebtedness, aircraft investment returns, and competitive environment.

• · The exchange offer is not conditioned upon any minimum principal amount of outstanding notes being tendered.
• · Tendering must be done through DTC's Automated Tender Offer Program (ATOP).
• · The exchange notes are substantially identical to the outstanding notes except that transfer restrictions, restrictive legends, registration rights, and Additional Interest provisions will not apply.
• · The company's fleet utilization rate was 99.5% for the six months ended June 30, 2026.
• · The company's fleet had a weighted average age of 4.8 years and a weighted average remaining lease term of 7.0 years as of June 30, 2026.
• · The Merger was completed on April 8, 2026, and the company's Class A Common Stock was delisted from the NYSE effective April 18, 2026.
• · The company no longer has an OEM orderbook after the Merger, which may impact its ability to manage its aircraft portfolio.